2Descombe J J,Duboung D,Picard M,et al. Pharmacokihetic study of rifaximin after oral administration in healthy volunteer [J].Jnt J Clipharm Res,1994,14(2):51-56.
3Hoover WW,,Gerlach EH,Hoban DJ,et al. Antimicrobial activity and spectrum of rifaximin a new topical rifamycin derivative [J].Diagn MicrobiolInfect Dis,16(2):111.
4Gillis JC,Brogden RN,Rifaximin.A review of its antibacterial activity,pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria [J].Drugs, 1995,49(3):467.
1Jiang Z D, Ke S, Palazzini E, et al. In vitro activity and fecal concentration of rifaximin after oral administration[J] Antimicrob Agents Chemother ,2000,44(8):2205
2Dupont H L, Jiang Z D, Ericsson C D, et al. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial [J]. Clin Infect Dis,2001,33(11): 1807
3Mas A, Rodes J, Sunyer L, et al. Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind,double-dummy, controlled clinical trial [J]. J Hepatol,2003; 38(1): 51
4Lawler J V, Wallace M R. Diagnosis and treatment of bacterial diarrhea [J]. Curr Gastroenterol Rep,2003,5 (4):287
5Tursi A. Acute diverticulitis of the colon--current medical therapeutic management [J]. Expert Opin Pharmacother,2004,5(1) :55
6Jiang Z D,Ke S,Palazzini E,et al.In vitro activity and fecal concentration of rifaximin after oral administration[J].Antimicrob Agents Chemother,2000,44 (8):2205
7Descombe J J,Dubourg D,Picard M,et al.Pharmacokinetic study of rifaximin after oral administration in healthy volunteers [J].Int J Clin Pharmacol Res,1994,14(2):51
8Rizzello F,Gionchetti P,Venturi A,et al.Rifaximin systemic absorption in patients with ulcerative colitis [J].Eur J Clin Pharmaco1,1998,54(1) :91
9Gionchetti P,Rizzello F,Ferrieri A,et al.Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid treatment:a double blind placebo-controlled trial [J].Dig Dis Sci,1999,44(6):1220
10Hoover W W,Gerlach E H,Hoban D J,et al.Antimicrobial activity and spectrum of rifaximin a new topical rifamycin derivative [J].Diagn Microbiol Infect Dis,1993,16(2):111
